OS Therapies Forms Subsidiary OS Drug Conjugates and Initiates Review of Strategic Options for its tunable ADC & Drug Conjugates Platforms
OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the formation of subsidiary OS Drug Conjugates (OSDC). The formation of OSDC coincides with formal strategic options initiatives to create value from the Company's leading-edge, patented silicone dioxide-based, pH sensitive tunable antibody drug conjugates (tADC) & other tunable drug conjugates (tDC) platforms. The Company has initiated discussions with clinical-stage ADC therapeutics companies in the U.S., China and other jurisdictions to form joint ventures (JVs) pairing those companies' clinical-stage assets with certain assets from the tADC and/or tDC platforms and spinning the JVs into standalone public companies. If successful, OS Therapies intends to provide stock dividends of the public JVs to shareholders.
The OST-tADC and OST-tDC technologies are centered around the Company's proprietary next-generation tunable Antibody Drug Conjugate (tADC) and tunable Drug Conjugates (tDC) platforms. These advanced technologies incorporate pH-sensitive silicon-based linkers: SiLinkers™ to link the targeting antibodies (or antibody fragments) and therapeutic moieties together while coating the entire package with pH sensitive coating. This strategy can release multiple therapeutic agents selectively within the tumor and tumor microenvironment, which have lower pH levels than the rest of the body. This approach aims to maximize the therapeutic effects while minimizing damage to healthy cells.
BCC Research estimates that the global market for antibody-drug conjugates is estimated to increase from $10.8 billion in 2023 to $47.0 billion by 2029, at a compound annual growth rate (CAGR) of 28.4% from 2024 through 2029.
About OS Therapies
OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OST-HER2, the Company's lead asset, is an immunotherapy leveraging the immune-stimulatory effects of Listeria bacteria to initiate a strong immune response targeting the HER2 protein. OST-HER2 has received rare pediatric disease, fast-track and orphan drug designations from the USFDA. The Company has completed enrollment for a 41-patient Phase 2b clinical trial of OST-HER2 in recurrent, fully resected, lung metastatic osteosarcoma, with positive results released in the first quarter of 2025. The Company anticipates submitting a Biologics Licensing Application (BLA) to the US FDA for OST-HER2 in osteosarcoma in 2025 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma.
In addition, OS Therapies is advancing its next-generation Antibody Drug Conjugate (ADC) platform, known as tunable ADC (tADC), which features tunable, tailored antibody-linker-payload candidates. This platform leverages the Company's proprietary silicone linker and Conditionally Active Payload (CAP) technology, enabling the delivery of multiple payloads per linker. For more information, please visit www.ostherapies.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements within the meaning of the federal securities laws. These forward-looking statements and terms such as 'anticipate,' 'expect,' 'intend,' 'may,' 'will,' 'should' or other comparable terms involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of OS Therapies and members of its management, as well as the assumptions on which such statements are based. OS Therapies cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to the approval of OST-HER2 by the US FDA and grant of a priority review voucher and other risks and uncertainties described in 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' in the Company's registration statement on Form S-1 filed with the Securities and Exchange Commission (the 'SEC') on November 12, 2024, as amended on November 27, 2024, and other subsequent documents we file with the SEC, including but not limited to our Quarterly Reports on Form 10-Q. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by the federal securities laws, OS Therapies specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
Jack Doll
571.243.9455
[email protected]://x.com/OSTherapies
https://www.instagram.com/ostherapies/
https://www.facebook.com/OSTherapies/
SOURCE: OS Therapies, Inc.
Copyright Business Wire 2025.
PUB: 02/24/2025 07:25 AM/DISC: 02/24/2025 07:25 AM
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Hurricane-related tax relief: 4 tips to help you weather the financial aftermath
As hurricane season begins, experts are sounding the alarm. The 2025 season could bring up to 19 named storms, including potentially five major hurricanes, marking an above-average year for the Atlantic basin. Homeowners are urged to prepare now and understand tax relief options that may soften potential financial hardships due to rising repair costs. Last year, Hurricane Helene caused over $78 billion dollars in damages, according to the National Oceanic and Atmospheric Administration (NOAA). Hurricane season runs from June 1 through Nov. 30 each year. 'Hurricanes can be financially devastating,' says Paul Miller, a certified public accountant (CPA) and managing partner of Miller & Company in New York City. 'Beyond property damage, there's often a major disruption to employment and income, plus out-of-pocket costs for temporary housing, food and repairs.' The good news is that homeowners can get at least some financial and tax relief after a natural disaster strikes. From claiming casualty loss deductions to taking more time to file your tax return, there are key tax breaks that can help. 'The financial recovery process can stretch for years, and having access to tax relief can make a meaningful difference,' Miller says. If you experience damage from a hurricane, you may be able to claim a casualty loss deduction on your federal income tax return. A casualty loss refers to damage or destruction, or an unusual event, such as a hurricane, tornado, or flood. For tax years 2018 through 2025, individuals can claim a casualty loss only if the event is a federally declared disaster. If your loss isn't attributed to a federally declared disaster, you generally won't be able to claim it. 'Unless Congress extends these provisions from the Tax Cuts and Jobs Act (TCJA), we'll likely revert to the pre-2018 rules, which allowed individuals to deduct personal casualty losses even when not linked to a federally declared disaster,' Miller says. If that happens, it 'would broaden the deduction again and could benefit taxpayers experiencing localized or personal property damage that isn't declared a disaster area by the federal government,' he says. To calculate the amount of your claim, start with the smaller of the property's cost or the decrease in its value. Then, subtract the following items: Any insurance or other reimbursements from the casualty loss $100. 10 percent of your adjusted gross income (AGI). When these reductions are taken into account, the amount left over is your casualty loss deduction. Under current tax rules: To claim a casualty loss, you typically need to itemize your deductions using Schedule A and complete Form 4684, which reports gains and losses from casualties and thefts. However, if the loss is considered a qualified disaster loss, which is a specific catastrophic event identified by the IRS (you can find a list here), you can claim the deduction without itemizing. A qualified disaster loss is not subject to the 10 percent reduction in AGI, and the $100 subtraction increases to $500. It is best to seek a CPA or tax professional to help you deduct the correct amount on your tax return. Learn more: Standard deduction vs. itemized deductions: Pros, cons and how to decide When filing your tax return, you'll need to provide documentation substantiating your casualty loss. That's why it's a good idea to take photos and videos of your home and personal property ahead of hurricane season, especially high-value items such as jewelry and collectibles. IRS Publication 584 helps taxpayers document a list of personal property. Here's more on how homeowners can prepare for a hurricane. In some cases after a hurricane, you may decide to sell your home. Typically, after you sell a property at a gain, the profit is taxable, but most homeowners qualify for a valuable capital gain tax exclusion. Specifically, if the home was your primary residence for at least two out of five years before the sale, you'll likely qualify to exclude up to $250,000 of the gain from your taxable income or up to $500,000 if you're married and filing jointly. To qualify for the gain exclusion, you must meet the ownership and use test, which requires that you both owned and lived in the home as your main residence for at least two of the five years leading up to the sale. You're generally not eligible for the exclusion if you've already claimed it on another home sale within the past two years. However, if you lose your home due to a natural disaster, such as a hurricane, you may still qualify to exclude some of the gain — even if you don't fully meet the ownership and use tests — under the IRS' unforeseeable circumstance provision. Under this provision, the IRS allows you to qualify for the gain exclusion if your home was destroyed due to a hurricane or other disaster. You can find more information on this IRS page to see if you qualify. If you're impacted by a natural disaster, such as a hurricane, special tax relief may apply to retirement account withdrawals and repayments. A withdrawal made due to a hurricane may count as a qualified disaster recovery distribution. While the amount is generally taxable, you won't face the 10 percent early withdrawal penalty, normally applied to those under age 59 ½ who withdraw from a retirement account like an IRA or 401(k). To qualify, your withdrawal must: Be from an eligible retirement plan, including a 401(k) or a traditional, SIMPLE or Roth IRA. Be no more than $22,000. Occur on the date of the disaster or later, but no more than 180 days later than the date of the disaster declaration (or the date the disaster started or Dec. 29, 2022, whichever is later). There are additional eligibility rules. Check out this IRS page for more. Learn more: Taxes on IRA and 401(k) withdrawals: What you should know The IRS allows you to choose to report the full amount in the year of distribution or spread the taxable income evenly over three years. For example, if you received a $24,000 qualified disaster recovery distribution in 2025, you can include $8,000 in 2025, 2026 and 2027. You also have the option to repay the full amount within three years from the day of receiving the distribution. If you repay the distribution, the withdrawal is no longer taxable. However, you may need to amend the prior year's tax return to reflect the repayment. Miller suggests if you withdraw funds through a qualified disaster distribution and later decide to repay the amount, you should track your repayment carefully. Also, you must report both the original distribution and repayment amount on Form 8915 (the specific version depends on the disaster year). Learn more: Form 1040-X: How to file an amended tax return After a severe hurricane or other natural event, the IRS typically extends the deadlines to file and pay taxes, and may offer penalty relief. If you live in a federally declared disaster area, generally you don't need to contact the IRS — the IRS automatically identifies affected taxpayers. However, in some cases — for example, if you recently moved to the area where the disaster happened — you may need to contact the IRS disaster assistance hotline at 866.562.5227. If you're affected by a hurricane or natural disaster, visit this IRS page on tax relief in disaster situations and this IRS FAQ page, or call the hotline to learn what specific tax relief options are available to you. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
24 minutes ago
- Business Wire
RDDT Investors Have Opportunity to Join Reddit, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reddit, Inc. ('Reddit' or 'the Company') (NYSE: RDDT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Despite a significant portion of Reddit's traffic coming from individuals performing Google searches, the Company claimed that Google's shift to AI in search results would not have a material impact on its user growth. Analyst Baird cut its price target for the Company's shares on May 21, 2025, citing its concerns on the very issue of Google's AI answers causing users to stop visiting Reddit. Based on this news, shares of Reddit fell by over 9%. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Business Wire
24 minutes ago
- Business Wire
Omega Announces Pricing of Its $600,000,000 Senior Notes Offering
HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) ('Omega') today announced that it priced an underwritten public offering of $600,000,000 aggregate principal amount of 5.200% Senior Notes due 2030 (the '2030 Notes'). The settlement of this offering is expected to occur on June 20, 2025, subject to customary closing conditions. Omega intends to use the net proceeds from the offering for general corporate purposes, which may include, among other things, repayment of existing indebtedness and future acquisition or investment opportunities in healthcare-related real estate properties and to pay certain fees and expenses related to the Offering. The 2030 Notes are guaranteed by Omega's subsidiary, OHI Healthcare Properties Limited Partnership, and will be guaranteed by Omega's existing and future subsidiaries that guarantee unsecured indebtedness for money borrowed of Omega in a principal amount at least equal to $100 million. Wells Fargo Securities, LLC, BofA Securities, Inc., Credit Agricole Securities (USA) Inc. and J.P. Morgan Securities LLC are acting as active joint book-running managers for the offering of the 2030 Notes. The 2030 Notes will mature on July 1, 2030, have an issue price to the public of 99.118% and feature a fixed-rate coupon of 5.200% per annum, payable semiannually on January 1 and July 1 of each year, beginning January 1, 2026. The offering is being conducted by means of a prospectus supplement filed as part of a shelf registration statement on Form S-3 (Registration No. 333-282376) previously filed with the Securities and Exchange Commission (the 'SEC'). A copy of the preliminary prospectus supplement and accompanying prospectus relating to the offering of the Notes can be obtained from: Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, MN 55402, Attention: WFS Customer Service, or by email at wfscustomerservice@ or by calling (800) 645-3751; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attention: Prospectus Department or by email at Credit Agricole Securities (USA) Inc., 1301 Avenue of the Americas, 8th Floor, New York, New York 10019, Attention: Debt Capital Markets, or by email at DCMNewYork@ or by calling +1 (866) 807-6030; J.P. Morgan Securities LLC, 383 Madison Ave., New York, NY 10179, Attention: Investment Grade Syndicate Desk, or by calling (212) 834 4533. Potential investors should read the prospectus supplement and accompanying prospectus, the registration statement and the other documents that Omega has filed with the SEC in connection with the offering of the Notes. A copy of the prospectus supplement and accompanying prospectus may also be obtained without charge by visiting the SEC's website at This press release shall not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful. Omega is a real estate investment trust ('REIT') that invests in the long-term healthcare industry, primarily in skilled nursing ('SNFs') and assisted living facilities ('ALFs'). Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the United States, as well as in the United Kingdom. More information on Omega is available at Forward-Looking Statements This press release includes forward-looking statements within the meaning of the federal securities laws. All statements regarding Omega's or its tenants', operators', borrowers' or managers' expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, facility transitions, growth opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations and statements that include words such as 'anticipate,' 'if,' 'believe,' 'plan,' 'estimate,' 'expect,' 'intend,' 'may,' 'could,' 'should,' 'will' and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from Omega's expectations. Omega's actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of Omega's properties, including those relating to reimbursement by third-party payors, regulatory matters, occupancy levels and quality of care, including the management of infectious diseases; (ii) the timing of our operators' recovery from staffing shortages, increased costs and decreased occupancy resulting from inflation and the long-term impacts of the Novel coronavirus ('COVID-19') pandemic and the sufficiency of previous government support and current reimbursement rates to offset such costs and the conditions related thereto; (iii) additional regulatory and other changes in the healthcare sector, including potential changes to Medicaid or Medicare reimbursements, state regulatory initiatives or minimum staffing requirements for skilled nursing facilities ('SNFs') that may further exacerbate labor and occupancy challenges for Omega's operators; (iv) the ability of any of Omega's operators in bankruptcy to reject unexpired lease obligations, modify the terms of Omega's mortgages and impede the ability of Omega to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations, and other costs and uncertainties associated with operator bankruptcies; (v) changes in tax laws and regulations affecting real estate investment trusts ('REITs'), including as the result of any policy changes driven by the current focus on capital providers to the healthcare industry; (vi) Omega's ability to re-lease, otherwise transition or sell underperforming assets or assets held for sale on a timely basis and on terms that allow Omega to realize the carrying value of these assets or to redeploy the proceeds therefrom on favorable terms, including due to the potential impact of changes in the SNF and assisted living facility ('ALF') markets or local real estate conditions; (vii) the availability and cost of capital to Omega; (viii) changes in Omega's credit ratings and the ratings of its debt securities; (ix) competition in the financing of healthcare facilities; (x) competition in the long-term healthcare industry and shifts in the perception of various types of long-term care facilities, including SNFs and ALFs; (xi) changes in the financial position of Omega's operators; (xii) the effect of economic, regulatory and market conditions generally, and particularly in the healthcare industry and in jurisdictions where we conduct business, including the U.K.; (xiii) changes in interest rates and the impacts of inflation and changes in global tariffs; (xiv) the timing, amount and yield of any additional investments; (xv) Omega's ability to maintain its status as a REIT; (xvi) the effect of other factors affecting our business or the businesses of Omega's operators that are beyond Omega's or operators' control, including natural disasters, public health crises or pandemics, cyber threats and governmental action, particularly in the healthcare industry, and (xvii) other factors identified in Omega's filings with the Securities and Exchange Commission. Statements regarding future events and developments and Omega's future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements. We caution you that the foregoing list of important factors may not contain all the material factors that are important to you. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available to us on the date of this release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.
